Isidro Da Silva

Credentials: Emeritus Visiting Scientist

Email: isidro.dasilva@cnrs-orleans.fr

Isidro Da Silva is a research engineer from the CEMHTI Laboratory, overseen by the French CNRS (Centre National de la Recherche Scientifique). He arrived in Madison in August 2019 for a one-year internship. He is interested in  production of manganese-52g for bimodality imaging and erbium-165 for dosimetry applications in case of Auger therapy. He is working on the radiochemical separation and dosimetry Auger studies of erbium-165.

  • L. Frealle, J. Vaudon , G. Audiger , E. Dutillly, M. Gervais, E. Sursin, C. Ruggeri, F.Duval, M.-L. Bouchetou, A. Bombard, I. Da Silva, “”First Steps at the Cyclotron of Orléans in the Radiochemistry of Radiometals: 52Mn and 165Er“, 2018, Instruments 2(3) 15.
  • P. K. Malikidogo, I. Da Silva, J-F. Morfin, S. Lacerda, L. Barentin, T. Sauvage, J. Sobilo, S. Lerondel, E. Toth and C. Bonnet, A cocktail of Er-165(III) and Gd(III) complexes for quantitative detection of zinc using SPECT and MRI“, 2018, Chemical Communications 54 7597-7600.
  • 3. C Michotte, M Nonis, D Bergeron, J Cessna, R Fitzgerald, L Pibida, B Zimmerman, A Fenwick, K Ferreira, J Keightley and I Da Silva “ Activity measurements of the radionuclides 18F and 64Cu for the NIST, USA in the ongoing comparisons BIPM.RI(II)-K4.F-18 and BIPM.RI(II)-K4.Cu-64” 2017 Metrologia 54 06011
  • D. Sergentu, A. Sabatié-Gogova, C. Alliot, N. Guo, D. Teze, F. Bassal, I. Da Silva, R. Maurice, J. Champion, N. Galland, G. Montavon, « Advances on the determination of the Astatine Pourbaix diagram : predomination of AtO(OH)2-over Atin Basic conditions » , Chemistry-A European Journal, 2016, 22, 9, 2964.
  • M.N. Amiot, M. M. Bé, T. Branger, P. Cassette, M. C. Lépy, Y. Ménesguen, I. Da Silva,Standardization of 64Cu using an improved decay scheme”, Nucl. Instrum. Meth. A, 2012, 684, 21, 97.
  • F. Guérard, H. Rajerison, A. Faivre-Chauvet, J. Barbet, G. Meyer, F. Haddad, I. Da Silva, J.-F. Gestin, « Radiolabelling of proteins with stabilised hypervalent astatine-211 : feasibility and stability », J. Nucl. Med., 2011, 52, S1.